Clinical Trial Update: Trial to Evaluate the Ability of a Single Infusion of High-Density Lipoprotein (HDL) to Modulate Markers of Cerebral Ischaemia [NA]

View source ↗

Summary

A completed clinical trial evaluated whether a single infusion of high-density lipoprotein (HDL) can modulate biomarkers of cerebral ischaemia in patients with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• High-Density Lipoprotein (HDL) infusion (high-density lipoprotein infusion)

Snippet

Sponsor: St George's, University of London | Conditions: Stroke | NA | Status: COMPLETED